Anti-Ligand Antibodies as Potential Auto Antigens: in Vitro and in Vivo Characteristics of Anti-Bungarotoxin Antibodies in the Idiotype Network

References

• Lu B-Z, Couraud P-O, Schmutz A, Strosberg AD. The internal image of catecholamines: expression and regulation of a functional network. Ann NY Acad Sci 1983; 418: 240–247
   PubMed Web of Science ®Google Scholar
• Bach JF. Antireceptor or antihormone autoimmunity and its relationship with the idiotype network. Adv Nephr 1987; 16: 251–280
   PubMedGoogle Scholar
• Sege K, Peterson PA. Use of anti-idiotypic antibodies as cell surface receptor probes. Proc Natl Acad Sci USA 1978; 75: 2443–2447
   PubMed Web of Science ®Google Scholar
• Elias D, Rapaport M, Cohen I R, Schechter Y. Desensitization of the insulin receptor by antireceptor antibodies in vivo is blocked by treatment of mice with beta-adrenergic agonists. J Clin Invest 1988; 81: 1979–1985
   PubMed Web of Science ®Google Scholar
• Schreiber A B, Couraud P O, Andre C, Vray B, Strosberg AD. Anti-alprenolol anti-idiotype antibodies bind to βadrenergic receptors and modulate catecholamine-sensitive adenylate cyclase. Proc Natl Acad Sci USA 1980; 77: 7385–7389
   PubMed Web of Science ®Google Scholar
• Nepom JJ. Identification of a hemagglutinin-specific idiotype associated with reovirus recognition shared by lymphoid and neural cells. J Exp Med 1982; 155: 155
   PubMed Web of Science ®Google Scholar
• Pachner AR. Myasthenia gravis. Immunology and Allergy Clinics of North America 1988; 8: 277–293
   Web of Science ®Google Scholar
• Cleveland W L, Wassermann N H, Sarangaragan R. Monoclonal antibodies to the acetylcholine receptor by a normally functioning autoantiidiotypic mechanism. Nature 1983; 305: 56
   PubMed Web of Science ®Google Scholar
• Pachner AR. Erlendsson KE, Kantor FS. Neuromuscular disease induced by the internal image of cobra neurotoxin. Ann NY Acad Sci 1987; 505: 788
   Web of Science ®Google Scholar
• Pachner A R, Ricalton NR. In vitro neutralization of bungaro toxin binding to acetylcholine receptor by monoclonal antibodies. Toxicon 1989; 27: 1263–1268
   PubMed Web of Science ®Google Scholar
• Galfre G, Milstein C. Preparation of monoclonal antibodies: Strategies and procedures. Meth Enzymol 1981; 73: 3–46
   PubMedGoogle Scholar
• Danse J-M, Toussaint J-L, Kempf J. Neutralization of alpha-bungarotoxin by monoclonal antibodies. Toxicon 1986; 24: 141–151
   PubMed Web of Science ®Google Scholar
• Schubert D, Harris A J, Devine C E, Heinemann S. Characterization of a unique muscle cell line. J Cell Biology 1974; 61: 398–413
   PubMed Web of Science ®Google Scholar
• Pachner A R, Kantor FS. The relationship of clinical disease to antibody tiler, proliferative response, and neurophysiology in murine experimental autoimmune myasthenia gravis. Clin Exp Immunol 1983; 51: 543
   PubMed Web of Science ®Google Scholar
• Pachner A R, Sourojon M, Fuchs S. Anti-idiotypic antibodies to anti-acetylcholine receptor antibody: characterization by ELISA and immunoprecipitation assays. J Neuroimmun 1986; 12: 205–214
   PubMed Web of Science ®Google Scholar
• Takemori T, Tesch H, Reth M, Rajewsky K. The immune response against anti-idiotypic antibodies. I. Induction of idiotope-bearing antibody and analysis of idiotope repertoire. Eur J Immunol 1982; 12: 1040
   PubMed Web of Science ®Google Scholar
• Sacks D L, Sher A. Evidence that anti-idiotype induced immunity to experimental African trypanosomiasis is genetically restricted and requires recognition of combining site related idiotopes. J Immunol 1983; 131: 1511–1515
   PubMed Web of Science ®Google Scholar
• Pachner A R, Kantor FS. AChR-specific helper T-cell lines in murine myasthenia. Clin Immunol Immunopath 1985; 35: 245
   PubMedGoogle Scholar
• Pachner AR. Anti-acetylcholine receptor antibodies block bungarotoxin binding to native human acetylcholine receptor antibody. Neurology 1989; 39: 1057–1060
   PubMed Web of Science ®Google Scholar
• Albuquerque E X, Warnick J E, Mayer R F, Eldefrawi A T, Eldefrawi ME. Recent Advances in the Molecular Mechanisms of Human and Animal Models of Myasthenia Gravis 1981; 496–518
   Google Scholar
• Pachner AR. Experimental models of myasthenia gravis: lessons in autoimmunity and progress toward better forms of treatment. Yale J Biol Med 1987; 60: 169
   PubMed Web of Science ®Google Scholar
• Francotte M, Urbain J. Induction of anti-tobacco mosaic virus antibodies in mice by rabbit antiidiotypic antibodies. J Exp Med 1984; 160: 1485–1494
   PubMed Web of Science ®Google Scholar
• Sharpe A H, Gaulton G N, McDade K K, Fields B N, Greene ML. Syngeneic monoclonal antiidiotype can induce cellular immunity to reovirus. J Exp Med 1984; 160: 1195–1205
   PubMed Web of Science ®Google Scholar
• Sacks D L, Esser K, Sher A. Immunization of mice against African trypanosomiasis using antiidiotype antibodies. J Exp Med 1982; 155: 1108–1119
   PubMed Web of Science ®Google Scholar
• Stein K E, Soderstrom T. Neonatal administration of idiotype or antiidiotype primes for protection against Escherichia coli K13. infection. J Exp Med 1984; 160: 1001–1011
   PubMed Web of Science ®Google Scholar
• Kennedy R C, Melnick J L, Dreesman GR. Antibody to hepatitis B virus induced by injecting antibodies to the idiotype. Science 1984; 223: 930–931
   PubMed Web of Science ®Google Scholar
• Oswald R, Sobel A, Waksman G, Roques B, Changeux J-P. Selective labelling by [3H] trimethisoquin azide of polypeptide chains present in acetylcholine receptor-rich membranes from. Torpedo marmorata. FEBS Letters 1980; 111: 29–34
   PubMed Web of Science ®Google Scholar
• Wilson P T, Hawrot E, Lentz TL. Distribution of alpha-bungarotoxin binding sites over residues 173–204 of the alpha-subunit of the acetylcholine receptor. Mol Pharmacol 1988; 34: 643–650
   PubMed Web of Science ®Google Scholar
• Schmidt J, Raftery MA. A simple assay for the study of solubilizeed acetylcholine receptors. Analytical Biochemistry 1973; 52: 349–354
   PubMed Web of Science ®Google Scholar
• Erlanger BF. Some thoughts on the structural basis of internal. imagery. Immunology Today 1989; 10: 151–152
   PubMed Web of Science ®Google Scholar